Michael Houghton, the institute's other director and a Nobel laureate, said the initiative would focus on so-called "small-molecule" drugs — chemically-synthesized drugs that make up the great majority of what's in people's medicine cabinets. Ibuprofen, for example, is a small-molecule drug.
Read more >